Cargando…
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Heart failure (HF) is a global pandemic which affects about 26 million people. PFKM (Phosphofructokinase, Muscle), catalyzing the phosphorylation of fructose-6-phosphate, plays a very important role in cardiovascular diseases. However, the effect of PFKM in glycolysis and HF remains to be elucidated...
Autores principales: | Zhou, Min, Sun, Xiao, Wang, Chunli, Wang, Fengdan, Fang, Chuibi, Hu, Zhenlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266090/ https://www.ncbi.nlm.nih.gov/pubmed/35804014 http://dx.doi.org/10.1038/s41598-022-15743-0 |
Ejemplares similares
-
The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
por: Gao, Wenwen, et al.
Publicado: (2021) -
ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM
por: Zhou, Yanming, et al.
Publicado: (2021) -
Didymin attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress
por: Chen, Rongchang, et al.
Publicado: (2021) -
Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis
por: Jiang, Lai, et al.
Publicado: (2020) -
PFKM gene defect and glycogen storage disease GSDVII with misleading enzyme histochemistry
por: Auranen, Mari, et al.
Publicado: (2015)